Functionalized Graphene Quantum Dots as an Eco-Friendly Fluorescent Probe for Galantamine Analysis: Greenness Evaluation With Application to Pharmacokinetics Monitoring – PubMed Black Hawk Supplements

Abstract

In this study, the use of functionalized graphene quantum dots (GQDs) as a fluorescent probe has been investigated for the quantitative determination of galantamine, a choline esterase inhibitor used for the treatment of Alzheimer’s disease. The GQDs exhibit a significant quenching in their fluorescence intensity upon interaction with galantamine allowing for sensitive and selective detection of the drug. This quenching process follows a dynamic pattern with a linear relationship between fluorescence intensity and the concentration of galantamine. Several factors affecting the quenching process were investigated and optimized, including the concentration of GQDs, the pH of the solution, and the incubation time. The proposed probe exhibited excellent analytical performance with a linear range of 10-500 ng/mL, a limit of detection of 15 ng/mL, accuracy of 100.78 ± 0.698%, and intraday and interday precision of 0.742 and 1.369%, respectively. Furthermore, the GQDs-based sensor exhibited good selectivity towards galantamine in the presence of potentially interfering substances. Another advantage of the GQDs-based sensor is its greenness evaluation, as it offers a more environmentally friendly alternative compared to traditional methods. In addition, the GQDs-based sensor was successfully applied to analyze galantamine in pharmaceutical samples and in vivo samples, demonstrating its potential for pharmacokinetics monitoring.

Keywords: GQDs; Galantamine; fluorescence; green chemistry.

Similar articles

• Graphene quantum dots as eco-friendly fluorescent probes for sensitive and selective determination of lumateperone in pharmaceutical preparation: Greenness and blueness assessment.

  Alqahtani AS, Almutairi FM, Aldhafeeri MM, Althobaiti YS, Abduljabbar MH, Serag A, Almalki AH. Alqahtani AS, et al. Spectrochim Acta A Mol Biomol Spectrosc. 2025 Feb 15;327:125342. doi: 10.1016/j.saa.2024.125342. Epub 2024 Oct 28. Spectrochim Acta A Mol Biomol Spectrosc. 2025. PMID: 39486237

• Depressing time: Waiting, melancholia, and the psychoanalytic practice of care.

  Salisbury L, Baraitser L. Salisbury L, et al. In: Kirtsoglou E, Simpson B, editors. The Time of Anthropology: Studies of Contemporary Chronopolitics. Abingdon: Routledge; 2020. Chapter 5. In: Kirtsoglou E, Simpson B, editors. The Time of Anthropology: Studies of Contemporary Chronopolitics. Abingdon: Routledge; 2020. Chapter 5. PMID: 36137063 Free Books & Documents. Review.

• Galantamine for dementia due to Alzheimer’s disease and mild cognitive impairment.

  Lim AWY, Schneider L, Loy C. Lim AWY, et al. Cochrane Database Syst Rev. 2024 Nov 5;11(11):CD001747. doi: 10.1002/14651858.CD001747.pub4. Cochrane Database Syst Rev. 2024. PMID: 39498781

• Garlic peel-based carbon quantum dots as a sustainable alternative for the sensitive and green spectrofluorometric quantification of molnupiravir in pharmaceutical capsules.

  Saber YA, Hamed M, Emara S, Mansour FR, Locatelli M, Ibrahim N. Saber YA, et al. Heliyon. 2024 Nov 26;10(23):e40661. doi: 10.1016/j.heliyon.2024.e40661. eCollection 2024 Dec 15. Heliyon. 2024. PMID: 39698097 Free PMC article.

• Drug therapy for obstructive sleep apnoea in adults.

  Mason M, Welsh EJ, Smith I. Mason M, et al. Cochrane Database Syst Rev. 2013 May 31;2013(5):CD003002. doi: 10.1002/14651858.CD003002.pub3. Cochrane Database Syst Rev. 2013. PMID: 23728641 Free PMC article. Review.

References

MeSH terms

Substances

Grants and funding